Cargando…

Immune Cells Profiles in the Different Sites of COVID-19-Affected Lung Lobes in a Single Patient

Whereas the COVID-19 disease pathophysiology is under investigation, it is important to identify the pathways of viral transmission and inflammation from the pre-illness to the disease-onset stages. We analyzed five lung lobes from a patient with COVID-19 who finally died after prolonged lung protec...

Descripción completa

Detalles Bibliográficos
Autores principales: Iwabuchi, Sadahiro, Miyamoto, Kyohei, Hatai, Mayuko, Mikasa, Yurina, Katsuda, Masahiro, Murata, Shin-ichi, Kondo, Toshikazu, Yamaue, Hiroki, Hashimoto, Shinichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8888686/
https://www.ncbi.nlm.nih.gov/pubmed/35252273
http://dx.doi.org/10.3389/fmed.2022.841170
_version_ 1784661216237453312
author Iwabuchi, Sadahiro
Miyamoto, Kyohei
Hatai, Mayuko
Mikasa, Yurina
Katsuda, Masahiro
Murata, Shin-ichi
Kondo, Toshikazu
Yamaue, Hiroki
Hashimoto, Shinichi
author_facet Iwabuchi, Sadahiro
Miyamoto, Kyohei
Hatai, Mayuko
Mikasa, Yurina
Katsuda, Masahiro
Murata, Shin-ichi
Kondo, Toshikazu
Yamaue, Hiroki
Hashimoto, Shinichi
author_sort Iwabuchi, Sadahiro
collection PubMed
description Whereas the COVID-19 disease pathophysiology is under investigation, it is important to identify the pathways of viral transmission and inflammation from the pre-illness to the disease-onset stages. We analyzed five lung lobes from a patient with COVID-19 who finally died after prolonged lung protective ventilation. Pathological examination revealed moderate inflammation in upper lung lobes and uneven yet severe inflammation and diffuse alveolar damage in lower lung lobes. SARS-CoV-2 was detected at higher levels not in severely, but rather moderately inflamed middle lung lobes, and immunohistochemistry and bulk RNA-sequencing results showed that immune cells were detected at higher levels in lower lung lobes. The mRNA expression of cytokine families varied. We found an increase in keratin 5- or aquaporin 3-expressing basal cells in the severely inflamed lower lung lobes, and the alveolar stromal tissues were filled with them. Thus, this analysis of lung samples from a patient helps to determine the COVID-19 pathophysiology at a specific time point, and the virus localization and inflammatory responses at each site of the lungs provide various important indications.
format Online
Article
Text
id pubmed-8888686
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-88886862022-03-03 Immune Cells Profiles in the Different Sites of COVID-19-Affected Lung Lobes in a Single Patient Iwabuchi, Sadahiro Miyamoto, Kyohei Hatai, Mayuko Mikasa, Yurina Katsuda, Masahiro Murata, Shin-ichi Kondo, Toshikazu Yamaue, Hiroki Hashimoto, Shinichi Front Med (Lausanne) Medicine Whereas the COVID-19 disease pathophysiology is under investigation, it is important to identify the pathways of viral transmission and inflammation from the pre-illness to the disease-onset stages. We analyzed five lung lobes from a patient with COVID-19 who finally died after prolonged lung protective ventilation. Pathological examination revealed moderate inflammation in upper lung lobes and uneven yet severe inflammation and diffuse alveolar damage in lower lung lobes. SARS-CoV-2 was detected at higher levels not in severely, but rather moderately inflamed middle lung lobes, and immunohistochemistry and bulk RNA-sequencing results showed that immune cells were detected at higher levels in lower lung lobes. The mRNA expression of cytokine families varied. We found an increase in keratin 5- or aquaporin 3-expressing basal cells in the severely inflamed lower lung lobes, and the alveolar stromal tissues were filled with them. Thus, this analysis of lung samples from a patient helps to determine the COVID-19 pathophysiology at a specific time point, and the virus localization and inflammatory responses at each site of the lungs provide various important indications. Frontiers Media S.A. 2022-02-16 /pmc/articles/PMC8888686/ /pubmed/35252273 http://dx.doi.org/10.3389/fmed.2022.841170 Text en Copyright © 2022 Iwabuchi, Miyamoto, Hatai, Mikasa, Katsuda, Murata, Kondo, Yamaue and Hashimoto. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Iwabuchi, Sadahiro
Miyamoto, Kyohei
Hatai, Mayuko
Mikasa, Yurina
Katsuda, Masahiro
Murata, Shin-ichi
Kondo, Toshikazu
Yamaue, Hiroki
Hashimoto, Shinichi
Immune Cells Profiles in the Different Sites of COVID-19-Affected Lung Lobes in a Single Patient
title Immune Cells Profiles in the Different Sites of COVID-19-Affected Lung Lobes in a Single Patient
title_full Immune Cells Profiles in the Different Sites of COVID-19-Affected Lung Lobes in a Single Patient
title_fullStr Immune Cells Profiles in the Different Sites of COVID-19-Affected Lung Lobes in a Single Patient
title_full_unstemmed Immune Cells Profiles in the Different Sites of COVID-19-Affected Lung Lobes in a Single Patient
title_short Immune Cells Profiles in the Different Sites of COVID-19-Affected Lung Lobes in a Single Patient
title_sort immune cells profiles in the different sites of covid-19-affected lung lobes in a single patient
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8888686/
https://www.ncbi.nlm.nih.gov/pubmed/35252273
http://dx.doi.org/10.3389/fmed.2022.841170
work_keys_str_mv AT iwabuchisadahiro immunecellsprofilesinthedifferentsitesofcovid19affectedlunglobesinasinglepatient
AT miyamotokyohei immunecellsprofilesinthedifferentsitesofcovid19affectedlunglobesinasinglepatient
AT hataimayuko immunecellsprofilesinthedifferentsitesofcovid19affectedlunglobesinasinglepatient
AT mikasayurina immunecellsprofilesinthedifferentsitesofcovid19affectedlunglobesinasinglepatient
AT katsudamasahiro immunecellsprofilesinthedifferentsitesofcovid19affectedlunglobesinasinglepatient
AT muratashinichi immunecellsprofilesinthedifferentsitesofcovid19affectedlunglobesinasinglepatient
AT kondotoshikazu immunecellsprofilesinthedifferentsitesofcovid19affectedlunglobesinasinglepatient
AT yamauehiroki immunecellsprofilesinthedifferentsitesofcovid19affectedlunglobesinasinglepatient
AT hashimotoshinichi immunecellsprofilesinthedifferentsitesofcovid19affectedlunglobesinasinglepatient